Got Trouble with Hair Loss? Buy Finasteride 1mg for Sale

Hair loss in men sometimes leads to baldness.  If you happen to see a bald man who seems to have lost their hair instead of having their head shaved bald, then they have male pattern baldness.  Male pattern baldness is actually a genetic condition that you inherit from your parents.  If you are a male and have older brothers or a dad who suffers from this hair loss condition, it is likely that you too will have inherited the condition and will soon suffer from it.  Normally, the condition of male pattern baldness can start as early as your late teens and will manifest by the time you reach your mid-twenties.

Although treatments are available for hair loss, they only manage to slow down the progression of the hair loss.  The true treatment for hair fall is called finasteride 1mg.  You can find finasteride 1mg for sale at your local pharmacy and you can also find finasteride 1mg for sale online.  The truth is that many buy their finasteride 1mg treatment online because they are able to get better savings by buying their hair fall meds on the internet.

In the past, there was really no effective treatment for hair loss aside from topical treatment that only attempt to slow down the progression of the genetic condition.  However, when Merck created the drug finasteride, everything about treating hair loss changed as the drug they actually made prevented the creation of the hormone that was responsible in the damaging and thinning of hair follicles which led to the thinning and dying of hair strands.  Although the discovery was accidental as finasteride was originally intended for another purpose, in the end, what they actually made was a very effective remedy for hair loss. Read more…

MS and the powers that be


At least 55,000 Canadians have multiple sclerosis, 3,500 of whom live in Saskatchewan. No one’s sure why our country is home to so many MS sufferers. Brad Wall, Premier of Saskatchewan, has taken a bold move in promising to help finance clinical trials on an unproven but promising new treatment – the “liberation procedure.” He’d like other premiers to follow suit. However, Ontario Premier Dalton McGuinty isn’t convinced the controversial treatment is ready for testing. So, afflicted Canadians are traveling to Bulgaria, Poland, Costa Rica, Italy and India, where the procedure is available, to benefit -- even if only minimally – from any relief it may offer, at an average of $30,000 a pop.

MS patients may have a range of symptoms that include balance problems, vision impairment, muscle spasms and weakness, diplopia, dysphagia, extreme fatigue, chronic or acute pain, and bladder and bowel difficulties, including incontinence. And the majority tends to live about as long as the healthy population.

It seems only natural that a minimally invasive procedure would be worth the risk to such individuals.

Dr. Paolo Zamboni, an Italian neurologist and director of vascular diseases, came up with the liberation therapy theory at the University of Ferrara, while trying to help his wife, who has the disease ). Examination of the venous system of MS patients showed that 90% had stenosis or restricted valves in the jugular and azygos veins, interfering with blood draining. He also found high levels of iron deposits in their brains, which he surmised might be the cause of the abnormal MS immune response, where the immune system attacks the myelin sheath of brain and spinal cord nerves, causing scarring and plaques.

Dr. Zamboni dubbed the phenomenon “chronic cerebrospinal venous insufficiency” and used a type of angioplasty to relieve the blockage in these veins. He found 73% of his patients improved. But after about nine months, “re-stenosis” made it necessary to repeat the procedure.

Despite this drawback, it seems clear, with so many positive anecdotal reports on the Internet, that Canadian governments should consider giving more attention to this possible break-through therapy. Either that, or launching a thorough investigation of Canadian Hutterites, a group known to have a much lower than average risk of contracting MS.